Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Non-cash Items (2016 - 2020)

Historic Non-cash Items for United Therapeutics (UTHR) over the last 10 years, with Q1 2020 value amounting to $74.1 million.

  • United Therapeutics' Non-cash Items fell 4832.64% to $74.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $74.1 million, marking a year-over-year decrease of 4832.64%. This contributed to the annual value of $3.9 million for FY2019, which is 9500.2% down from last year.
  • Latest data reveals that United Therapeutics reported Non-cash Items of $74.1 million as of Q1 2020, which was down 4832.64% from $3.9 million recorded in Q4 2019.
  • In the past 5 years, United Therapeutics' Non-cash Items ranged from a high of $171.2 million in Q4 2017 and a low of $3.1 million during Q3 2017
  • Its 5-year average for Non-cash Items is $59.4 million, with a median of $48.0 million in 2016.
  • In the last 5 years, United Therapeutics' Non-cash Items tumbled by 9845.1% in 2016 and then soared by 519733.46% in 2017.
  • Quarter analysis of 5 years shows United Therapeutics' Non-cash Items stood at $3.2 million in 2016, then soared by 5197.33% to $171.2 million in 2017, then tumbled by 54.09% to $78.6 million in 2018, then crashed by 95.0% to $3.9 million in 2019, then surged by 1786.26% to $74.1 million in 2020.
  • Its Non-cash Items stands at $74.1 million for Q1 2020, versus $3.9 million for Q4 2019 and $108.4 million for Q3 2019.